Inorganic arsenic: A non-genotoxic carcinogen

Journal of Environmental Sciences (China)

Volumn 49, Issue , 2016, Pages 28-37

  Cohen, Samuel M ^a   Chowdhury, Aparajita ^a   Arnold, Lora L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Arsenic; Cancer; Cell proliferation; Cytotoxicity; Genotoxicity; Regeneration

Indexed keywords

ARSENIC; CELL DEATH; CELL PROLIFERATION; CELLS; CYTOLOGY; CYTOTOXICITY; LYMPHOCYTES;

BIOLOGICAL RESPONSE; CANCER; CANCER DEVELOPMENT; CHROMOSOMAL ABERRATION; GENOTOXICITIES; REGENERATION; SISTER CHROMATID EXCHANGE; SULFHYDRYL GROUPS;

DISEASES;

ARSENIC; CARCINOGEN; CELL ORGANELLE; DNA; EPIDEMIOLOGY; GENOTOXICITY; INORGANIC COMPOUND; REACTION KINETICS; REGENERATION;

NICOTIANA TABACUM;

ARSENIC; CARCINOGEN; INORGANIC COMPOUND;

CHROMOSOME ABERRATION; DNA DAMAGE; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; HUMAN; LYMPHOCYTE; MICRONUCLEUS TEST;

ARSENIC; CARCINOGENS; CHROMOSOME ABERRATIONS; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; HUMANS; INORGANIC CHEMICALS; LYMPHOCYTES; MICRONUCLEUS TESTS;

EID: 84971669563     PISSN: 10010742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jes.2016.04.015     Document Type: Review

References (92)

1. Abernathy, C.O., Chappell, W.R., Meek, M.E., Gibb, H., Guo, H.-R., Is ingested inorganic arsenic a “threshold” carcinogen?. Fundam. Appl. Toxicol. 29 (1996), 168–175.
2. Armitage, P., Doll, R., The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8 (1954), 1–12.
3. Arnold, L.L., Eldan, M., van Gemert, M., Capen, C.C., Cohen, S.M., Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice. Toxicology 190 (2003), 197–219.
4. Arnold, L.L., Suzuki, S., Yokohira, M., Kakiuchi-Kiyota, S., Pennington, K.L., Cohen, S.M., Time course of urothelial changes in rats and mice orally administered arsenite. Toxicol. Pathol. 42 (2013), 855–862.
5. Aylward, L.L., Ramasamy, S., Hays, S.M., Schoeny, R., Kirman, C.R., Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure. Regul. Toxicol. Pharmacol. 69 (2014), 49–54.
6. Banerjee, M., Sarma, N., Biswas, R., Roy, J., Mukherjee, A., Giri, A., DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions. Int. J. Cancer 123 (2008), 283–287.
7. Basu, A., Mahata, J., Gupta, S., Giri, A.K., Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488 (2001), 171–194.
8. Basu, A., Mahata, J., Roy, A.K., Sarkar, J.N., Poddar, G., Nandy, A.K., et al. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 516 (2002), 29–40.
9. Basu, A., Ghosh, P., Das, J.K., Banerjee, A., Ray, K., Giri, A.K., et al. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types. Cancer Epidemiol. Biomark. Prev. 13 (2004), 820–827.
10. Bull, C.F., Mayrhofer, G., Zeegers, D., Mun, G.L.K., Hande, M.P., Fenech, M., Folate deficiency is associated with the formation of complex nuclear anomalies in the cytokinesis-block micronucleus cytome assay. Environ. Mol. Mutagen. 53 (2012), 311–323.
11. Burgaz, S., Işcan, A., Büyükbingöl, Z.K., Bozkurt, A., Karakaya, A.E., Evaluation of micronuclei in exfoliated urothelial cells and urinary thioether excretion of smokers. Mutat. Res. 335 (1995), 163–169.
12. Byrd, D.M., Roegner, M.L., Griffiths, J.C., Lamm, S.H., Grumski, K.S., Wilson, R., et al. Carcinogenic risks of inorganic arsenic in perspective. Int. Arch. Occup. Environ. Health 68 (1996), 484–494.
13. Chen, C.J., Chuang, Y.C., Lin, T.M., Wu, H.Y., Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 45 (1985), 5895–5899.
14. Cohen, S.M., Arnold, L.L., Chemical carcinogenesis. Toxicol. Sci. 120:Suppl. 1 (2011), S76–S92.
15. Cohen, S.M., Ellwein, L.B., Cell proliferation in carcinogenesis. Science 249 (1990), 1007–1011.
16. Cohen, S.M., Ellwein, L.B., Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51 (1991), 6493–6505.
17. Cohen, S.M., Arnold, L.L., Uzvolgyi, E., Cano, M., St John, M., Yamamoto, S., et al. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15 (2002), 1150–1157.
18. Cohen, S.M., Arnold, L.L., Eldan, M., Lewis, A.S., Beck, B.D., Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36 (2006), 99–133.
19. Cohen, S.M., Ohnishi, T., Clark, N.M., He, J., Arnold, L.L., Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol. Pathol. 35 (2007), 337–347.
20. Cohen, S.M., Arnold, L.L., Beck, B.D., Lewis, A.S., Eldan, M., Evaluation of the carcinogenicity of inorganic arsenic. Crit. Rev. Toxicol. 43 (2013), 711–752.
21. Cullen, W.R., Is Arsenic an Aphrodisiac? The Sociochemistry of an Element. 2008, Royal Society of Chemistry, Cambridge, England.
22. Doak, S.H., Jenkins, G.J., Johnson, G.E., Quick, E., Parry, E.M., Parry, J.M., Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007), 3904–3911.
23. Dodmane, P.R., Arnold, L.L., Kakiuchi-Kiyota, S., Qiu, F., Liu, X., Rennard, S.I., et al. Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells. Toxicology 312 (2013), 18–29.
24. Dodmane, P.R., Arnold, L.L., Muirhead, D.E., Suzuki, S., Yokohira, M., Pennington, K.L., et al. Characterization of intracellular inclusions in the urothelium of mice exposed to inorganic arsenic. Toxicol. Sci. 137 (2014), 36–46.
25. Dodmane, P.R., Arnold, L.L., Pennington, K.L., Singh, R.K., Ferragut Cardoso, A.P., Cohen, S.M., Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells. Toxicol. Rep. 2 (2015), 833–837.
26. Ferreccio, C., Smith, A.H., Duran, V., Barlaro, T., Benitez, H., Valdes, R., et al. Case–control study of arsenic in drinking water and kidney cancer in uniquely exposed northern Chile. Am. J. Epidemiol. 178 (2013), 813–818.
27. Fierz, U., Follow-up studies of the side-effects of the treatment of skin diseases with inorganic arsenic. Dermatologica 131 (1965), 41–58.
28. Gamble, M.V., Liu, X., Ahsan, H., Pilsner, J.R., Ilievski, V., Slavkovich, V., et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am. J. Clin. Nutr. 84 (2006), 1093–1101.
29. Gamble, M.V., Liu, X., Slavkovich, V., Pilsner, J.R., Ilievski, V., Factor-Litvak, P., et al. Folic acid supplementation lowers blood arsenic. Am. J. Clin. Nutr. 86 (2007), 1202–1209.
30. Gentry, P.R., McDonald, T.B., Sullivan, D.E., Shipp, A.M., Yager, J.W., Clewell, H.J. III, Analysis of genomic dose–response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Mol. Mutagen. 51 (2010), 1–14.
31. Gentry, P.R., Clewell, H.J. III, Greene, T.B., Franzen, A.C., Yager, J.W., The impact of recent advances in research on arsenic cancer risk assessment. Regul. Toxicol. Pharmacol. 69 (2014), 91–104.
32. Gentry, P.R., Yager, J.W., Clewell, R.A., Clewell, H.J. III, Use of mode of action data to inform a dose–response assessment for bladder cancer following exposure to inorganic arsenic. Toxicol. in Vitro 28 (2014), 1196–1205.
33. Ghosh, P., Basu, A., Mahata, J., Basu, S., Sengupta, M., Das, J.K., et al. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int. J. Cancer 118 (2006), 2470–2478.
34. Ghosh, P., Banerjee, M., De Chaudhuri, S., Das, J.K., Sarma, N., Basu, A., et al. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic. Mutat. Res. 632 (2007), 104–110.
35. Ghosh, P., Basu, A., Singh, K.K., Giri, A.K., Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population. Mol. Cancer, 7, 2008, 45.
36. Greenfield, R.E., Ellwein, L.B., Cohen, S.M., A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis 5 (1984), 437–445.
37. Haque, R., Mazumder, D.N., Samanta, S., Ghosh, N., Kalman, D., Smith, M.M., et al. Arsenic in drinking water and skin lesions: dose–response data from West Bengal, India. Epidemiology 14 (2003), 174–182.
38. Harper, K.N., Liu, X., Hall, M.N., Ilievski, V., Oka, J., Calancie, L., et al. A dose–response study of arsenic exposure and markers of oxidative damage in Bangladesh. J. Occup. Environ. Med. 56 (2014), 652–658.
39. International Agency for Research on Cancer (IARC), Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum., 2004, 85.
40. International Agency for Research on Cancer (IARC), Arsenic, metals, fibres, and dusts. IARC Monogr. Eval. Carcinog. Risks Hum. 100 (2012), 41–93.
41. Kazimirova, A., Barancokova, M., Krajcovicova-Kudlackova, M., Volkovova, K., Staruchova, M., Valachovicova, M., et al. The relationship between micronuclei in human lymphocytes and selected micronutrients in vegetarians and non-vegetarians. Mutat. Res. 611 (2006), 64–70.
42. Kitchin, K.T., Wallace, K., Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-alpha. Toxicol. Appl. Pharmacol. 206 (2005), 66–72.
43. Kligerman, A.D., Doerr, C.L., Tennant, A.H., Harrington-Brock, K., Allen, J.W., Winkfiel, d.E., et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42 (2003), 192–205.
44. Lamm, S.H., Luo, Z.D., Bo, F.B., Zhang, G.Y., Zhang, Y.M., Wilson, R., et al. An epidemiologic study of arsenic-related skin disorders and skin cancer and the consumption of arsenic-contaminated well waters in Huhhot, Inner Mongolia, China. Hum. Ecol. Risk. Assess. 13 (2007), 713–746.
45. Lamm, S.H., Robbins, S., Chen, R., Lu, J., Goodrich, B., Feinleib, M., Discontinuity in the cancer slope factor as it passes from high to low exposure levels — arsenic in the BFD-endemic area. Toxicology 326 (2014), 25–35.
46. Lamm, S., Ferdosi, H., Dissen, E., Li, J., Ahn, J., A systematic review and meta-regression analysis of lung cancer risk and inorganic arsenic in drinking water. Int. J. Environ. Res. Public Health 12 (2015), 15498–15515.
47. Lindberg, H.K., Wang, X., Jarventaus, H., Falck, G.C.M., Norppa, H., Fenech, M., Origin of nuclear buds and micronuclei in normal and folate-deprived human lymphocytes. Mutat. Res. 617 (2007), 33–45.
48. Lu, M., Wang, H., Li, X.F., Arnold, L.L., Cohen, S.M., Le, X.C., Binding of dimethylarsinous acid to cys-13alpha of rat hemoglobin is responsible for the retention of arsenic in rat blood. Chem. Res. Toxicol. 20 (2007), 27–37.
49. Mahata, J., Chaki, M., Ghosh, P., Das, J.K., Baidya, K., Ray, K., et al. Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal, India. Cytogenet. Genome Res. 104 (2004), 359–364.
50. Mazumder, D.N., Arsenic and non-malignant lung disease. J. Environ. Sci. Health, Part A: Tox. Hazard. Subst. Environ. Eng. 42 (2007), 1859–1867.
51. Mazumder, D.N., Deb, D., Biswas, A., Saha, C., Nandy, A., Ganguly, B., et al. Evaluation of dietary arsenic exposure and its biomarkers: a case study of West Bengal, India. J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. 48 (2013), 896–904.
52. Mazumder, D.N., Haque, R., Ghosh, N., De, B.K., Santra, A., Chakraborti, D., et al. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 29 (2000), 1047–1052.
53. Melkonian, S., Argos, M., Pierce, B.L., Chen, Y., Islam, T., Ahmed, A., et al. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am. J. Epidemiol. 173 (2011), 183–191.
54. Milton, A.H., Rahman, M., Respiratory effects and arsenic contaminated well water in Bangladesh. Int. J. Environ. Health Res. 12 (2002), 175–179.
55. Mink, P.J., Alexander, D.D., Barraj, L.M., Kelsh, M.A., Tsuji, J.S., Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. Regul. Toxicol. Pharmacol. 52 (2008), 299–310.
56. Moolgavkar, S.H., Knudson, A.G.J., Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst. 66 (1981), 1037–1052.
57. Moore, L.E., Smith, A.H., Hopenhayn-Rich, C., Biggs, M.L., Kalman, D.A., Smith, M.T., Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol. Biomark. Prev. 6 (1997), 31–36.
58. National Research Council (NRC), Arsenic in Drinking Water. 1999, The National Academies Press, Washington, DC.
59. National Research Council (NRC), Arsenic in Drinking Water: 2001 Update. 2001, The National Academies Press, Washington, DC.
60. Nersesyan, A., Kundi, M., Atefie, K., Schulte-Hermann, R., Knasmüller, S., Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol. Biomark. Prev. 15 (2006), 1835–1840.
61. Nersesyan, A., Kundi, M., Fenech, M., Bolognesi, C., Misik, M., Wultsch, G., et al. Micronucleus assay with urine derived cells (UDC): a review of its application in human studies investigating genotoxin exposure and bladder cancer risk. Mutat. Res. Rev. Mutat. Res. 762 (2014), 37–51.
62. Nesnow, S., Roop, B.C., Lambert, G., Kadiiska, M., Mason, R.P., Cullen, W.R., et al. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15 (2002), 1627–1634.
63. Neubauer, O., Arsenical cancer: a review. Br. J. Cancer 1 (1947), 192–251.
64. Normandin, L., Ayotte, P., Levallois, P., Ibanez, Y., Courteau, M., Kennedy, G., et al. Biomarkers of arsenic exposure and effects in a Canadian rural population exposed through groundwater consumption. J. Expo. Sci. Environ. Epidemiol. 24 (2014), 127–134.
65. Parvez, F., Chen, Y., Brandt-Rauf, P.W., Bernard, A., Dumont, X., Slavkovich, V., et al. Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ. Health Perspect. 116 (2008), 190–195.
66. Parvez, F., Chen, Y., Brandt-Rauf, P.W., Slavkovich, V., Islam, T., Ahmed, A., et al. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the health effects of arsenic longitudinal study (HEALS). Thorax 65 (2010), 528–533.
67. Paul, S., Bhattacharjee, P., Mishra, P.K., Chatterjee, D., Biswas, A., Deb, D., et al. Human urothelial micronucleus assay to assess genotoxic recovery by reduction of arsenic in drinking water: a cohort study in West Bengal, India. Biometals 26 (2013), 855–862.
68. Peters, B.A., Hall, M.N., Liu, X., Parvez, F., Sanchez, T.R., van Geen, A., et al. Folic acid and creatine as therapeutic approaches to lower blood arsenic: a randomized controlled trial. Environ. Health Perspect. 123 (2015), 1294–1301.
69. Reali, D., Di Marino, F., Bahramandpour, S., Carducci, A., Barale, R., Loprieno, N., Micronuclei in exfoliated urothelial cells and urine mutagenicity in smokers. Mutat. Res. 192 (1987), 145–149.
70. Schuhmacher-Wolz, U., Dieter, H.H., Klein, D., Schneider, K., Oral exposure to inorganic arsenic: evaluation of its carcinogenic and noncarcinogenic effects. Crit. Rev. Toxicol. 39 (2009), 271–298.
71. Scudellari, M., The science myths that will not die. Nature 528 (2015), 322–325.
72. Sidhu, M.S., Desai, K.P., Lynch, H.N., Rhomberg, L.R., Beck, B.D., Venditti, F.J., Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment. Toxicology 331 (2015), 78–99.
73. Snow, E.T., Sykora, P., Durham, T.R., Klein, C.B., Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 207:2 Suppl. (2005), 557–564.
74. Soeteman-Hernández, L.G., Fellows, M.D., Johnson, G.E., Slob, W., Correlation of in vivo versus in vitro benchmark doses (BMDs) derived from micronuclei test data: a proof of concept study. Toxicol. Sci. 148 (2015), 355–367.
75. Stich, H.F., Rosin, M.P., Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention. Cancer Lett. 22 (1984), 241–253.
76. Suzuki, S., Arnold, L.L., Muirhead, D., Lu, X., Le, X.C., Bjork, J.A., et al. Inorganic arsenic-induced intramitochondrial granules in mouse urothelium. Toxicol. Pathol. 36 (2008), 999–1005.
77. Suzuki, S., Arnold, L.L., Pennington, K.L., Kakiuchi-Kiyota, S., Cohen, S.M., Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium. Toxicology 261 (2009), 41–46.
78. Suzuki, S., Arnold, L.L., Pennington, K.L., Chen, B., Naranmandura, H., Le, X.C., et al. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Toxicol. Appl. Pharmacol. 244 (2010), 99–105.
79. Thomas, D.J., Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 222 (2007), 365–373.
80. Thomas, D.J., Arsenolysis and thiol-dependent arsenate reduction. Toxicol. Sci. 117 (2010), 249–252.
81. Thomas, D.J., States, J.C., (eds.) The Chemistry and Metabolism of Arsenic. Arsenic: Exposure Sources, Health Risks and Mechanisms of Toxicity, 2014, Wiley.
82. Tseng, W.P., Chu, H.M., How, S., Fong, J.M., Lin, C.S., Yeh, S., Prevalence of skin cancer in an endemic area of chronic arsenism in Taiwan. J. Natl. Cancer Inst. 40 (1968), 453–463.
83. Tsuji, J.S., Alexander, D.D., Perez, V., Mink, P.J., Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses. Toxicology 317 (2014), 17–30.
84. Tsuji, J.S., Perez, V., Garry, M.R., Alexander, D.D., Association of low-level arsenic exposure in drinking water with cardiovascular disease. A systematic review and risk assessment. Toxicology 323 (2014), 78–94.
85. Tsuji, J.S., Garry, M.R., Perez, V., Chang, E.T., Low-level arsenic exposure and developmental neurotoxicity in children. A systematic review and risk assessment. Toxicology 337 (2015), 91–107.
86. von Ehrenstein, O.S., Mazumder, D.N., Yuan, Y., Samanta, S., Balmes, J., Sil, A., et al. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 162 (2005), 533–541.
87. Wang, Y.X., Feng, W., Zeng, Q., Sun, Y., Wang, P., You, L., et al. Variability of metal levels in spot, first morning, and 24-hour urine samples over a 3-month period in healthy adult Chinese men. Environ. Health Perspect. 124 (2016), 468–476.
88. Wedel, W.R., Muirhead, D.E., Arnold, L.L., Dodmane, P.R., Lele, S.M., Maness-Harris, L., et al. Urothelial cell intracytoplasmic inclusions after treatment of promyelocytic leukemia with arsenic trioxide. Toxicol. Sci. 134 (2013), 271–275.
89. Wei, M., Arnold, L.L., Cano, M., Cohen, S.M., Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium. Toxicol. Sci. 83 (2005), 237–245.
90. Yager, J.W., Gentry, P.R., Thomas, R.S., Pluta, L., Efremenko, A., Black, M., et al. Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites. Environ. Mol. Mutagen. 542 (2013), 82–98.
91. Yokohira, M., Arnold, L.L., Pennington, K.L., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., et al. Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+ 3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol. Appl. Pharmacol. 246 (2010), 1–7.
92. Yokohira, M., Arnold, L.L., Pennington, K.L., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., et al. Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+ 3 oxidation state) methyltransferase knockout mice. Toxicol. Sci. 121 (2011), 257–266.